Treatment of diabetic neuropathy with clofibrate.
D000293:Adolescent; D000368:Aged; D002784:Cholesterol / Q000097:blood; D002986:Clinical Trials as Topic; D002994:Clofibrate / Q000627:therapeutic use*; D003925:Diabetic Angiopathies / Q000517:prevention & control; D003929:Diabetic Neuropathies / Q000188:drug therapy*; D004035:Diet Therapy; D004576:Electromyography; D005260:Female; D006801:Humans; D008055:Lipids / Q000097:blood*; D008297:Male; D008875:Middle Aged; D009431:Neural Conduction; D010525:Peripheral Nerves / Q000187:drug effects; D010743:Phospholipids / Q000097:blood; D010919:Placebos; D011517:Prothrombin Time; D014280:Triglycerides / Q000097:blood; D014527:Uric Acid / Q000097:blood
D008055:Lipids; D010743:Phospholipids; D010919:Placebos; D014280:Triglycerides; D014527:Uric Acid; D002784:Cholesterol; D002994:Clofibrate